Veronique de Rugy has written an insightful column. Rugy writes
At the federal level, that means, among other things, radically reforming the Food and Drug Administration. The FDA is the perfect example of an agency that works by the “precautionary principle” norm. In the name of protecting people from everything at any cost — even against their will, if need be — it imposes an incredible regulatory burden on health care innovators, which then translates into higher costs and fewer new products available to consumers.
In some cases, the FDA’s intervention in the health care market slows down access to certain drugs, or it makes some drugs and technologies unaffordable to low-income individuals. In other cases, it actually drives innovators out of the market. In extreme cases, it kills people who could have been saved if they had had access to a drug or a technology.